The SCICONX Journal of Diabetes Complications and Management (JDCM) is committed to maintaining the highest standards of editorial integrity, transparency, and scientific quality. This editorial policy outlines the principles and practices that govern the evaluation, selection, and publication of manuscripts submitted to the journal.

Editorial Principles

This Journal operates on the foundation of:

• Scientific integrity – Ensuring accuracy, reliability, and reproducibility of published research
• Transparency – Maintaining clear and accountable editorial processes
• Fairness and impartiality – Evaluating manuscripts solely on academic merit
• Ethical responsibility – Upholding internationally recognized ethical standards
• Editorial independence – Ensuring decisions are free from external influence

Editorial Independence

The editorial decisions at JDCM are made independently by the editorial team. Decisions are based on:

• Scientific quality and originality
• Relevance to the journal’s scope
• Methodological rigor and validity

Editorial decisions are not influenced by:

• Commercial interests
• Institutional affiliations
• Author nationality, gender, or personal background

Peer Review Policy

All manuscripts submitted to the journal undergo a rigorous double-blind peer review process, ensuring unbiased evaluation.

• Minimum of two independent reviewers per manuscript
• Confidential handling of all submissions
• Editorial decisions based on reviewer recommendations and editorial judgment

The peer review process is designed to ensure that only high-quality, scientifically valid research is published.

Manuscript Evaluation Criteria

Editors and reviewers assess submissions based on:

• Originality and novelty of the research
• Scientific and methodological rigor
• Clarity of presentation and organization
• Relevance to diabetes complications and management
• Ethical compliance

Ethical Standards and Compliance

JDCM adheres to internationally recognized ethical guidelines, including those established by the Committee on Publication Ethics (COPE).

Authors must ensure:

• Ethical approval for studies involving humans or animals
• Informed consent from participants
• Proper acknowledgment of funding sources
• Disclosure of conflicts of interest

Misconduct and Malpractice

The journal has zero tolerance for unethical practices, including:

• Plagiarism
• Data fabrication or falsification
• Duplicate or redundant publication
• Improper authorship attribution

Any suspected misconduct will be investigated thoroughly, and appropriate actions will be taken, including rejection or retraction.

Corrections, Retractions, and Updates

The Journal is committed to maintaining the accuracy of the scientific record.

• Corrections will be issued for minor errors that do not affect the overall conclusions
• Retractions will be published in cases of significant errors or ethical violations
• Expressions of concern may be issued when investigations are ongoing

All updates will be clearly linked to the original article.

Editorial Responsibilities

Editors are responsible for:

• Making fair and unbiased decisions
• Maintaining confidentiality of submissions
• Managing conflicts of interest
• Ensuring timely processing of manuscripts
• Upholding ethical standards

Confidentiality

All submitted manuscripts are treated as confidential documents. Editors and reviewers must:

• Not disclose manuscript details to unauthorized individuals
• Not use unpublished data for personal or professional gain

Conflict of Interest

All participants in the publication process must disclose any conflicts of interest.

Editors will:

• Avoid handling manuscripts where a conflict exists
• Assign alternative editors when necessary

Data Transparency and Reproducibility

Authors are encouraged to:

• Provide sufficient methodological details
• Share datasets where applicable
• Ensure results are reproducible and verifiable

Open Access Policy

This Journal follows an open-access publishing model, ensuring that all articles are freely available to readers worldwide without subscription barriers.

Timeliness and Efficiency

The journal strives to:

• Provide timely editorial decisions
• Maintain efficient peer review timelines
• Communicate clearly with authors throughout the process

Appeals and Complaints

Authors may appeal editorial decisions by:

• Submitting a detailed justification
• Providing additional supporting information

All appeals are reviewed independently to ensure fairness and transparency.

Commitment to Quality

JDCM is dedicated to:

• Publishing high-quality, impactful research
• Supporting authors through constructive feedback
• Maintaining transparency and accountability in all processes

The editorial policy of this journal reflects its commitment to excellence in scientific publishing. By adhering to these principles, the journal aims to build trust within the academic community and contribute meaningfully to advancements in diabetes research and clinical practice.